Summary

The global Antibody Discovery and Development Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Antibody Discovery and Development Services refers to professional services for the research and development of new therapeutic antibodies. These services are typically provided by biotech companies, contract research organizations (CROs), or specialized antibody development facilities. These services are designed to help customers comprehensively advance the development of therapeutic antibodies from the early stages of antibody discovery to preclinical research and clinical trials. These services often require a combination of professional scientific knowledge and advanced experimental techniques, as well as a quality management system that meets regulatory standards to ensure the high quality and safety of the antibodies.
In 2025, the North America Antibody Discovery and Development Services market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Antibody Discovery and Development Services include Abcam, Abzena, AlivaMab Biologics, Alloy Therapeutics, Antibody Solutions, Aragen Bioscience, Aurigene Pharmaceutical Services, Biocytogen, Biomolecular Discovery Services, Biotem, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Antibody Discovery and Development Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Abcam
Abzena
AlivaMab Biologics
Alloy Therapeutics
Antibody Solutions
Aragen Bioscience
Aurigene Pharmaceutical Services
Biocytogen
Biomolecular Discovery Services
Biotem
Charles River Laboratories
ChemPartner
Creative Bioarray
Creative Biolabs
Curia
Eurofins
Evotec
GenScript
Integrated DNA Technologies
LakePharma
MorphoSys
NanoCellect
ProteoGenix
Rapid Novor
Sanofi
Syd Labs
Twist Bioscience
Yumab
Viva Biotech
WuXi Biologics
Segment by Type
Antibody Discovery Services
Antibody Production Services
Segment by Application
Pharmaceutical
Research
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Antibody Discovery and Development Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antibody Discovery and Development Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Antibody Discovery Services
1.2.3 Antibody Production Services
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Antibody Discovery and Development Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Antibody Discovery and Development Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Antibody Discovery and Development Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Antibody Discovery and Development Services Market Size and Prospective (2021-2032)
2.5.2 Europe Antibody Discovery and Development Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Antibody Discovery and Development Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Antibody Discovery and Development Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Antibody Discovery and Development Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Antibody Discovery and Development Services Historical Market Size by Type (2021-2026)
3.2 Global Antibody Discovery and Development Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Antibody Discovery and Development Services

4 Breakdown Data by Application
4.1 Global Antibody Discovery and Development Services Historical Market Size by Application (2021-2026)
4.2 Global Antibody Discovery and Development Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Antibody Discovery and Development Services Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Antibody Discovery and Development Services Players by Revenue (2021-2026)
5.1.2 Global Antibody Discovery and Development Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Antibody Discovery and Development Services Revenue
5.4 Global Antibody Discovery and Development Services Market Concentration Analysis
5.4.1 Global Antibody Discovery and Development Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Antibody Discovery and Development Services Revenue in 2025
5.5 Global Key Players of Antibody Discovery and Development Services Head Offices and Areas Served
5.6 Global Key Players of Antibody Discovery and Development Services, Product and Application
5.7 Global Key Players of Antibody Discovery and Development Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antibody Discovery and Development Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Antibody Discovery and Development Services Market Size by Type (2021-2026)
6.1.2.2 North America Antibody Discovery and Development Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Antibody Discovery and Development Services Market Size by Application (2021-2026)
6.1.3.2 North America Antibody Discovery and Development Services Market Share by Application (2021-2026)
6.1.4 North America Antibody Discovery and Development Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antibody Discovery and Development Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Antibody Discovery and Development Services Market Size by Type (2021-2026)
6.2.2.2 Europe Antibody Discovery and Development Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Antibody Discovery and Development Services Market Size by Application (2021-2026)
6.2.3.2 Europe Antibody Discovery and Development Services Market Share by Application (2021-2026)
6.2.4 Europe Antibody Discovery and Development Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Antibody Discovery and Development Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Antibody Discovery and Development Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Antibody Discovery and Development Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Antibody Discovery and Development Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Antibody Discovery and Development Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Antibody Discovery and Development Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Antibody Discovery and Development Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Antibody Discovery and Development Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Antibody Discovery and Development Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Antibody Discovery and Development Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Antibody Discovery and Development Services Market Share by Application (2021-2026)
6.4.4 Latin America Antibody Discovery and Development Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Antibody Discovery and Development Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Antibody Discovery and Development Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Antibody Discovery and Development Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Antibody Discovery and Development Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Antibody Discovery and Development Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Antibody Discovery and Development Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Abcam
7.1.1 Abcam Company Details
7.1.2 Abcam Business Overview
7.1.3 Abcam Antibody Discovery and Development Services Introduction
7.1.4 Abcam Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.1.5 Abcam Recent Development
7.2 Abzena
7.2.1 Abzena Company Details
7.2.2 Abzena Business Overview
7.2.3 Abzena Antibody Discovery and Development Services Introduction
7.2.4 Abzena Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.2.5 Abzena Recent Development
7.3 AlivaMab Biologics
7.3.1 AlivaMab Biologics Company Details
7.3.2 AlivaMab Biologics Business Overview
7.3.3 AlivaMab Biologics Antibody Discovery and Development Services Introduction
7.3.4 AlivaMab Biologics Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.3.5 AlivaMab Biologics Recent Development
7.4 Alloy Therapeutics
7.4.1 Alloy Therapeutics Company Details
7.4.2 Alloy Therapeutics Business Overview
7.4.3 Alloy Therapeutics Antibody Discovery and Development Services Introduction
7.4.4 Alloy Therapeutics Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.4.5 Alloy Therapeutics Recent Development
7.5 Antibody Solutions
7.5.1 Antibody Solutions Company Details
7.5.2 Antibody Solutions Business Overview
7.5.3 Antibody Solutions Antibody Discovery and Development Services Introduction
7.5.4 Antibody Solutions Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.5.5 Antibody Solutions Recent Development
7.6 Aragen Bioscience
7.6.1 Aragen Bioscience Company Details
7.6.2 Aragen Bioscience Business Overview
7.6.3 Aragen Bioscience Antibody Discovery and Development Services Introduction
7.6.4 Aragen Bioscience Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.6.5 Aragen Bioscience Recent Development
7.7 Aurigene Pharmaceutical Services
7.7.1 Aurigene Pharmaceutical Services Company Details
7.7.2 Aurigene Pharmaceutical Services Business Overview
7.7.3 Aurigene Pharmaceutical Services Antibody Discovery and Development Services Introduction
7.7.4 Aurigene Pharmaceutical Services Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.7.5 Aurigene Pharmaceutical Services Recent Development
7.8 Biocytogen
7.8.1 Biocytogen Company Details
7.8.2 Biocytogen Business Overview
7.8.3 Biocytogen Antibody Discovery and Development Services Introduction
7.8.4 Biocytogen Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.8.5 Biocytogen Recent Development
7.9 Biomolecular Discovery Services
7.9.1 Biomolecular Discovery Services Company Details
7.9.2 Biomolecular Discovery Services Business Overview
7.9.3 Biomolecular Discovery Services Antibody Discovery and Development Services Introduction
7.9.4 Biomolecular Discovery Services Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.9.5 Biomolecular Discovery Services Recent Development
7.10 Biotem
7.10.1 Biotem Company Details
7.10.2 Biotem Business Overview
7.10.3 Biotem Antibody Discovery and Development Services Introduction
7.10.4 Biotem Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.10.5 Biotem Recent Development
7.11 Charles River Laboratories
7.11.1 Charles River Laboratories Company Details
7.11.2 Charles River Laboratories Business Overview
7.11.3 Charles River Laboratories Antibody Discovery and Development Services Introduction
7.11.4 Charles River Laboratories Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.11.5 Charles River Laboratories Recent Development
7.12 ChemPartner
7.12.1 ChemPartner Company Details
7.12.2 ChemPartner Business Overview
7.12.3 ChemPartner Antibody Discovery and Development Services Introduction
7.12.4 ChemPartner Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.12.5 ChemPartner Recent Development
7.13 Creative Bioarray
7.13.1 Creative Bioarray Company Details
7.13.2 Creative Bioarray Business Overview
7.13.3 Creative Bioarray Antibody Discovery and Development Services Introduction
7.13.4 Creative Bioarray Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.13.5 Creative Bioarray Recent Development
7.14 Creative Biolabs
7.14.1 Creative Biolabs Company Details
7.14.2 Creative Biolabs Business Overview
7.14.3 Creative Biolabs Antibody Discovery and Development Services Introduction
7.14.4 Creative Biolabs Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.14.5 Creative Biolabs Recent Development
7.15 Curia
7.15.1 Curia Company Details
7.15.2 Curia Business Overview
7.15.3 Curia Antibody Discovery and Development Services Introduction
7.15.4 Curia Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.15.5 Curia Recent Development
7.16 Eurofins
7.16.1 Eurofins Company Details
7.16.2 Eurofins Business Overview
7.16.3 Eurofins Antibody Discovery and Development Services Introduction
7.16.4 Eurofins Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.16.5 Eurofins Recent Development
7.17 Evotec
7.17.1 Evotec Company Details
7.17.2 Evotec Business Overview
7.17.3 Evotec Antibody Discovery and Development Services Introduction
7.17.4 Evotec Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.17.5 Evotec Recent Development
7.18 GenScript
7.18.1 GenScript Company Details
7.18.2 GenScript Business Overview
7.18.3 GenScript Antibody Discovery and Development Services Introduction
7.18.4 GenScript Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.18.5 GenScript Recent Development
7.19 Integrated DNA Technologies
7.19.1 Integrated DNA Technologies Company Details
7.19.2 Integrated DNA Technologies Business Overview
7.19.3 Integrated DNA Technologies Antibody Discovery and Development Services Introduction
7.19.4 Integrated DNA Technologies Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.19.5 Integrated DNA Technologies Recent Development
7.20 LakePharma
7.20.1 LakePharma Company Details
7.20.2 LakePharma Business Overview
7.20.3 LakePharma Antibody Discovery and Development Services Introduction
7.20.4 LakePharma Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.20.5 LakePharma Recent Development
7.21 MorphoSys
7.21.1 MorphoSys Company Details
7.21.2 MorphoSys Business Overview
7.21.3 MorphoSys Antibody Discovery and Development Services Introduction
7.21.4 MorphoSys Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.21.5 MorphoSys Recent Development
7.22 NanoCellect
7.22.1 NanoCellect Company Details
7.22.2 NanoCellect Business Overview
7.22.3 NanoCellect Antibody Discovery and Development Services Introduction
7.22.4 NanoCellect Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.22.5 NanoCellect Recent Development
7.23 ProteoGenix
7.23.1 ProteoGenix Company Details
7.23.2 ProteoGenix Business Overview
7.23.3 ProteoGenix Antibody Discovery and Development Services Introduction
7.23.4 ProteoGenix Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.23.5 ProteoGenix Recent Development
7.24 Rapid Novor
7.24.1 Rapid Novor Company Details
7.24.2 Rapid Novor Business Overview
7.24.3 Rapid Novor Antibody Discovery and Development Services Introduction
7.24.4 Rapid Novor Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.24.5 Rapid Novor Recent Development
7.25 Sanofi
7.25.1 Sanofi Company Details
7.25.2 Sanofi Business Overview
7.25.3 Sanofi Antibody Discovery and Development Services Introduction
7.25.4 Sanofi Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.25.5 Sanofi Recent Development
7.26 Syd Labs
7.26.1 Syd Labs Company Details
7.26.2 Syd Labs Business Overview
7.26.3 Syd Labs Antibody Discovery and Development Services Introduction
7.26.4 Syd Labs Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.26.5 Syd Labs Recent Development
7.27 Twist Bioscience
7.27.1 Twist Bioscience Company Details
7.27.2 Twist Bioscience Business Overview
7.27.3 Twist Bioscience Antibody Discovery and Development Services Introduction
7.27.4 Twist Bioscience Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.27.5 Twist Bioscience Recent Development
7.28 Yumab
7.28.1 Yumab Company Details
7.28.2 Yumab Business Overview
7.28.3 Yumab Antibody Discovery and Development Services Introduction
7.28.4 Yumab Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.28.5 Yumab Recent Development
7.29 Viva Biotech
7.29.1 Viva Biotech Company Details
7.29.2 Viva Biotech Business Overview
7.29.3 Viva Biotech Antibody Discovery and Development Services Introduction
7.29.4 Viva Biotech Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.29.5 Viva Biotech Recent Development
7.30 WuXi Biologics
7.30.1 WuXi Biologics Company Details
7.30.2 WuXi Biologics Business Overview
7.30.3 WuXi Biologics Antibody Discovery and Development Services Introduction
7.30.4 WuXi Biologics Revenue in Antibody Discovery and Development Services Business (2021-2026)
7.30.5 WuXi Biologics Recent Development

8 Antibody Discovery and Development Services Market Dynamics
8.1 Antibody Discovery and Development Services Industry Trends
8.2 Antibody Discovery and Development Services Market Drivers
8.3 Antibody Discovery and Development Services Market Challenges
8.4 Antibody Discovery and Development Services Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Antibody Discovery and Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Antibody Discovery and Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Antibody Discovery and Development Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Antibody Discovery and Development Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Antibody Discovery and Development Services Revenue Share by Region (2021-2026)
Table 6. Global Antibody Discovery and Development Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Antibody Discovery and Development Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Antibody Discovery and Development Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Antibody Discovery and Development Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Antibody Discovery and Development Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Antibody Discovery and Development Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Antibody Discovery and Development Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Antibody Discovery and Development Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Antibody Discovery and Development Services Applications
Table 18. Global Antibody Discovery and Development Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Antibody Discovery and Development Services Market Share by Players (2021-2026)
Table 20. Global Top Antibody Discovery and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery and Development Services as of 2025)
Table 21. Ranking of Global Top Antibody Discovery and Development Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Antibody Discovery and Development Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Antibody Discovery and Development Services, Headquarters and Area Served
Table 24. Global Key Players of Antibody Discovery and Development Services, Product and Application
Table 25. Global Key Players of Antibody Discovery and Development Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Antibody Discovery and Development Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Antibody Discovery and Development Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Antibody Discovery and Development Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Antibody Discovery and Development Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Antibody Discovery and Development Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Antibody Discovery and Development Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Antibody Discovery and Development Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Antibody Discovery and Development Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Antibody Discovery and Development Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Antibody Discovery and Development Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Antibody Discovery and Development Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Antibody Discovery and Development Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. Abcam Company Details
Table 48. Abcam Business Overview
Table 49. Abcam Antibody Discovery and Development Services Product
Table 50. Abcam Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Abzena Company Details
Table 53. Abzena Business Overview
Table 54. Abzena Antibody Discovery and Development Services Product
Table 55. Abzena Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 56. Abzena Recent Development
Table 57. AlivaMab Biologics Company Details
Table 58. AlivaMab Biologics Business Overview
Table 59. AlivaMab Biologics Antibody Discovery and Development Services Product
Table 60. AlivaMab Biologics Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 61. AlivaMab Biologics Recent Development
Table 62. Alloy Therapeutics Company Details
Table 63. Alloy Therapeutics Business Overview
Table 64. Alloy Therapeutics Antibody Discovery and Development Services Product
Table 65. Alloy Therapeutics Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 66. Alloy Therapeutics Recent Development
Table 67. Antibody Solutions Company Details
Table 68. Antibody Solutions Business Overview
Table 69. Antibody Solutions Antibody Discovery and Development Services Product
Table 70. Antibody Solutions Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 71. Antibody Solutions Recent Development
Table 72. Aragen Bioscience Company Details
Table 73. Aragen Bioscience Business Overview
Table 74. Aragen Bioscience Antibody Discovery and Development Services Product
Table 75. Aragen Bioscience Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 76. Aragen Bioscience Recent Development
Table 77. Aurigene Pharmaceutical Services Company Details
Table 78. Aurigene Pharmaceutical Services Business Overview
Table 79. Aurigene Pharmaceutical Services Antibody Discovery and Development Services Product
Table 80. Aurigene Pharmaceutical Services Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 81. Aurigene Pharmaceutical Services Recent Development
Table 82. Biocytogen Company Details
Table 83. Biocytogen Business Overview
Table 84. Biocytogen Antibody Discovery and Development Services Product
Table 85. Biocytogen Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 86. Biocytogen Recent Development
Table 87. Biomolecular Discovery Services Company Details
Table 88. Biomolecular Discovery Services Business Overview
Table 89. Biomolecular Discovery Services Antibody Discovery and Development Services Product
Table 90. Biomolecular Discovery Services Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 91. Biomolecular Discovery Services Recent Development
Table 92. Biotem Company Details
Table 93. Biotem Business Overview
Table 94. Biotem Antibody Discovery and Development Services Product
Table 95. Biotem Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 96. Biotem Recent Development
Table 97. Charles River Laboratories Company Details
Table 98. Charles River Laboratories Business Overview
Table 99. Charles River Laboratories Antibody Discovery and Development Services Product
Table 100. Charles River Laboratories Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 101. Charles River Laboratories Recent Development
Table 102. ChemPartner Company Details
Table 103. ChemPartner Business Overview
Table 104. ChemPartner Antibody Discovery and Development Services Product
Table 105. ChemPartner Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 106. ChemPartner Recent Development
Table 107. Creative Bioarray Company Details
Table 108. Creative Bioarray Business Overview
Table 109. Creative Bioarray Antibody Discovery and Development Services Product
Table 110. Creative Bioarray Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 111. Creative Bioarray Recent Development
Table 112. Creative Biolabs Company Details
Table 113. Creative Biolabs Business Overview
Table 114. Creative Biolabs Antibody Discovery and Development Services Product
Table 115. Creative Biolabs Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 116. Creative Biolabs Recent Development
Table 117. Curia Company Details
Table 118. Curia Business Overview
Table 119. Curia Antibody Discovery and Development Services Product
Table 120. Curia Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 121. Curia Recent Development
Table 122. Eurofins Company Details
Table 123. Eurofins Business Overview
Table 124. Eurofins Antibody Discovery and Development Services Product
Table 125. Eurofins Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 126. Eurofins Recent Development
Table 127. Evotec Company Details
Table 128. Evotec Business Overview
Table 129. Evotec Antibody Discovery and Development Services Product
Table 130. Evotec Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 131. Evotec Recent Development
Table 132. GenScript Company Details
Table 133. GenScript Business Overview
Table 134. GenScript Antibody Discovery and Development Services Product
Table 135. GenScript Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 136. GenScript Recent Development
Table 137. Integrated DNA Technologies Company Details
Table 138. Integrated DNA Technologies Business Overview
Table 139. Integrated DNA Technologies Antibody Discovery and Development Services Product
Table 140. Integrated DNA Technologies Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 141. Integrated DNA Technologies Recent Development
Table 142. LakePharma Company Details
Table 143. LakePharma Business Overview
Table 144. LakePharma Antibody Discovery and Development Services Product
Table 145. LakePharma Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 146. LakePharma Recent Development
Table 147. MorphoSys Company Details
Table 148. MorphoSys Business Overview
Table 149. MorphoSys Antibody Discovery and Development Services Product
Table 150. MorphoSys Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 151. MorphoSys Recent Development
Table 152. NanoCellect Company Details
Table 153. NanoCellect Business Overview
Table 154. NanoCellect Antibody Discovery and Development Services Product
Table 155. NanoCellect Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 156. NanoCellect Recent Development
Table 157. ProteoGenix Company Details
Table 158. ProteoGenix Business Overview
Table 159. ProteoGenix Antibody Discovery and Development Services Product
Table 160. ProteoGenix Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 161. ProteoGenix Recent Development
Table 162. Rapid Novor Company Details
Table 163. Rapid Novor Business Overview
Table 164. Rapid Novor Antibody Discovery and Development Services Product
Table 165. Rapid Novor Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 166. Rapid Novor Recent Development
Table 167. Sanofi Company Details
Table 168. Sanofi Business Overview
Table 169. Sanofi Antibody Discovery and Development Services Product
Table 170. Sanofi Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 171. Sanofi Recent Development
Table 172. Syd Labs Company Details
Table 173. Syd Labs Business Overview
Table 174. Syd Labs Antibody Discovery and Development Services Product
Table 175. Syd Labs Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 176. Syd Labs Recent Development
Table 177. Twist Bioscience Company Details
Table 178. Twist Bioscience Business Overview
Table 179. Twist Bioscience Antibody Discovery and Development Services Product
Table 180. Twist Bioscience Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 181. Twist Bioscience Recent Development
Table 182. Yumab Company Details
Table 183. Yumab Business Overview
Table 184. Yumab Antibody Discovery and Development Services Product
Table 185. Yumab Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 186. Yumab Recent Development
Table 187. Viva Biotech Company Details
Table 188. Viva Biotech Business Overview
Table 189. Viva Biotech Antibody Discovery and Development Services Product
Table 190. Viva Biotech Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 191. Viva Biotech Recent Development
Table 192. WuXi Biologics Company Details
Table 193. WuXi Biologics Business Overview
Table 194. WuXi Biologics Antibody Discovery and Development Services Product
Table 195. WuXi Biologics Revenue in Antibody Discovery and Development Services Business (2021-2026) & (US$ Million)
Table 196. WuXi Biologics Recent Development
Table 197. Antibody Discovery and Development Services Market Trends
Table 198. Antibody Discovery and Development Services Market Drivers
Table 199. Antibody Discovery and Development Services Market Challenges
Table 200. Antibody Discovery and Development Services Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources

List of Figures
Figure 1. Antibody Discovery and Development Services Product Picture
Figure 2. Global Antibody Discovery and Development Services Market Share by Type: 2025 vs 2032
Figure 3. Antibody Discovery Services Features
Figure 4. Antibody Production Services Features
Figure 5. Global Antibody Discovery and Development Services Market Share by Application: 2025 vs 2032
Figure 6. Pharmaceutical
Figure 7. Research
Figure 8. Others
Figure 9. Antibody Discovery and Development Services Report Years Considered
Figure 10. Global Antibody Discovery and Development Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Antibody Discovery and Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Antibody Discovery and Development Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Antibody Discovery and Development Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Antibody Discovery and Development Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Antibody Discovery and Development Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Antibody Discovery and Development Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Antibody Discovery and Development Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Antibody Discovery and Development Services Market Share by Players in 2025
Figure 19. Global Top Antibody Discovery and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery and Development Services as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Antibody Discovery and Development Services Revenue in 2025
Figure 21. North America Antibody Discovery and Development Services Market Share by Type (2021-2026)
Figure 22. North America Antibody Discovery and Development Services Market Share by Application (2021-2026)
Figure 23. Europe Antibody Discovery and Development Services Market Share by Type (2021-2026)
Figure 24. Europe Antibody Discovery and Development Services Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Antibody Discovery and Development Services Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Antibody Discovery and Development Services Market Share by Application (2021-2026)
Figure 27. Latin America Antibody Discovery and Development Services Market Share by Type (2021-2026)
Figure 28. Latin America Antibody Discovery and Development Services Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Antibody Discovery and Development Services Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Antibody Discovery and Development Services Market Share by Application (2021-2026)
Figure 31. Abcam Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 32. Abzena Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 33. AlivaMab Biologics Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 34. Alloy Therapeutics Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 35. Antibody Solutions Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 36. Aragen Bioscience Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 37. Aurigene Pharmaceutical Services Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 38. Biocytogen Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 39. Biomolecular Discovery Services Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 40. Biotem Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 41. Charles River Laboratories Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 42. ChemPartner Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 43. Creative Bioarray Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 44. Creative Biolabs Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 45. Curia Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 46. Eurofins Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 47. Evotec Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 48. GenScript Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 49. Integrated DNA Technologies Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 50. LakePharma Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 51. MorphoSys Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 52. NanoCellect Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 53. ProteoGenix Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 54. Rapid Novor Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 55. Sanofi Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 56. Syd Labs Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 57. Twist Bioscience Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 58. Yumab Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 59. Viva Biotech Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 60. WuXi Biologics Revenue Growth Rate in Antibody Discovery and Development Services Business (2021-2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed